We are live on ! Find out more
CAS

CTC Alternative Strategies Portfolio holdings

AUM $44M
1-Year Est. Return 43.15%
This Fund
S&P 500
This Quarter Est. Return
-2.14%
1 Year Est. Return
+43.15%
3 Year Est. Return
+76.07%
5 Year Est. Return
10 Year Est. Return
AUM
$236M
AUM Growth
+$75.3M
Cap. Flow
+$76.1M
Cap. Flow %
32.27%
Top 10 Hldgs %
42.03%
Holding
297
New
168
Increased
7
Reduced
5
Closed
117

Sector Composition

Rank Sector Weight
1 Industrials 14%
2 Healthcare 12.15%
3 Financials 12.09%
4 Technology 9.03%
5 Consumer Discretionary 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
26
Bank of America
BAC
$442B
$1.7M 0.72%
+42,810
New +$1.64M
CEG icon
27
Constellation Energy
CEG
$95.7B
$1.69M 0.72%
+8,445
New +$1.72M
WFC icon
28
Wells Fargo
WFC
$268B
$1.68M 0.71%
+28,347
New +$1.67M
DE icon
29
Deere & Co
DE
$167B
$1.64M 0.7%
+4,395
New +$1.71M
MTD icon
30
Mettler-Toledo International
MTD
$28.8B
$1.64M 0.69%
+1,171
New +$1.6M
WRK
31
DELISTED
WestRock Company
WRK
$1.63M 0.69%
+32,396
New +$1.64M
PH icon
32
Parker-Hannifin
PH
$125B
$1.62M 0.69%
+3,200
New +$1.72M
TDG icon
33
TransDigm Group
TDG
$70.7B
$1.59M 0.67%
+1,241
New +$1.59M
IQV icon
34
IQVIA
IQV
$37.5B
$1.52M 0.65%
+7,200
New +$1.64M
JNJ icon
35
Johnson & Johnson
JNJ
$611B
$1.52M 0.65%
+10,400
New +$1.55M
IBB icon
36
iShares Biotechnology ETF
IBB
$9.32B
$1.5M 0.63%
+10,900
New +$1.46M
MRVL icon
37
Marvell Technology
MRVL
$199B
$1.48M 0.63%
+21,165
New +$1.48M
A icon
38
Agilent Technologies
A
$39.3B
$1.45M 0.62%
+11,200
New +$1.57M
COP icon
39
ConocoPhillips
COP
$144B
$1.45M 0.62%
+12,675
New +$1.54M
LIN icon
40
Linde
LIN
$224B
$1.4M 0.6%
+3,200
New +$1.41M
APH icon
41
Amphenol
APH
$211B
$1.37M 0.58%
+20,400
New +$1.29M
CARR icon
42
Carrier Global
CARR
$54B
$1.34M 0.57%
+21,192
New +$1.3M
NU icon
43
Nu Holdings
NU
$70.3B
$1.33M 0.57%
+103,442
New +$1.2M
ROK icon
44
Rockwell Automation
ROK
$49.5B
$1.32M 0.56%
+4,803
New +$1.3M
MRSH
45
Marsh
MRSH
$90.8B
$1.26M 0.54%
+6,000
New +$1.23M
PYPL icon
46
PayPal
PYPL
$49.7B
$1.21M 0.51%
+20,800
New +$1.32M
XBI icon
47
State Street SPDR S&P Biotech ETF
XBI
$9.85B
$1.21M 0.51%
+13,000
New +$1.17M
VRTX icon
48
Vertex Pharmaceuticals
VRTX
$121B
$1.17M 0.5%
+2,500
New +$1.09M
MAR icon
49
Marriott International
MAR
$89.6B
$1.15M 0.49%
+4,777
New +$1.15M
TXN icon
50
Texas Instruments
TXN
$259B
$1.14M 0.48%
+5,842
New +$1.08M

Similar funds

CTC Alternative Strategies's Q2 2024 Portfolio in Review

As of Q2 2024, CTC Alternative Strategies held 297 positions worth $236M, up 47% from $160M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

CTC Alternative Strategies deployed $76.1M of net new capital in Q2 2024, opening 168 new positions and adding to 7 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 90,000 shares worth $8.26M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 4.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Kimberly-Clark, an estimated $1.32M trimmed.

  • CTC Alternative Strategies's largest Q2 2024 buy was iShares 20+ Year Treasury Bond ETF: 90,000 shares worth $8.26M.
  • CTC Alternative Strategies added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2024, an estimated $26.7M increase.
  • CTC Alternative Strategies's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $1.32M.
  • CTC Alternative Strategies fully exited iShares Bitcoin Trust in Q2 2024, selling an estimated $27.7M.
  • CTC Alternative Strategies's ten largest holdings make up 42% of its $236M portfolio in Q2 2024.
  • CTC Alternative Strategies opened 168 new positions and closed 117 in Q2 2024.
  • CTC Alternative Strategies's portfolio value rose 47% quarter-over-quarter to $236M.

Based on CTC Alternative Strategies's 13F filing for Q2 2024, filed 2 Aug 2024.